Related Articles

• New multi-disciplinary treatment modality with RALS for patients with esophageal cancer.
• Enteral lorlatinib after immune hyperprogression as a treatment option for anaplastic lymphoma kinase‑positive non‑small cell lung cancer: A case report
• Residual esophageal necrosis after radical esophagectomy for esophagogastric cancer: A case report
• Percutaneous and endobronchial high dose rate brachytherapy for lung cancer
• Second-line chemotherapy for refractory small cell neuroendocrine carcinoma of the esophagus that relapsed after complete remission with irinotecan plus cisplatin therapy: Case report and review of the literature